KURIYEL RALF 4
4 · REPLIGEN CORP · Filed Mar 12, 2024
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
KURIYEL RALF
Senior VP, R&D
Transactions
- Exercise/Conversion
Common Stock
2024-03-11$86.10/sh+1,271$109,433→ 27,777 total - Sale
Common Stock
2024-03-11$193.73/sh−3,517$681,348→ 24,260 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-11+1,271→ 0 totalExercise: $86.10Exp: 2030-02-27→ Common Stock (1,271 underlying)
Footnotes (2)
- [F1]$193.73 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.64 to $194.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]This option is fully vested and exercisable.